Skip to main content

and
  1. No Access

    Article

    Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis

    In Australia, many patients who are initiated on asthma controller inhalers receive combination inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) despite having asthma of sufficiently low severity that ...

    Tracey-Lea Laba, Helen K. Reddel, Nicholas J. Zwar, Guy B. Marks in PharmacoEconomics (2019)